Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saradha Rajamani

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 16, 2023
Automating Ground Truth Annotations for Gland Segmentation Through ImmunohistochemistryTushar Kataria, Saradha Rajamani, Abdul Bari Ayubi, et al.
Future Science OA|September 9, 2017
Analytical validation of a 12-gene molecular test for the prediction of distant recurrence in breast cancerM Bryan Warf, Saradha Rajamani, Kristin Krappmann, et al.
Cancer Reports (Hoboken, N.J.)|August 23, 2021
Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsyJack M Cuzick, Steven Stone, Lauren Lenz, et al.
Cancer Biomarkers : Section a of Disease Markers|September 26, 2015
Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resectionEric J Askeland, Vincent A Chehval, Ryan W Askeland, et al.
European Urology|November 5, 2018
Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate CancerDaniel J Canter, Julia Reid, Maria Latsis, et al.
Prostate Cancer and Prostatic Diseases|June 28, 2019
Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapyDaniel J Canter, Stephen Freedland, Saradha Rajamani, et al.
Urologic Oncology|April 16, 2018
Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillanceDaniel W Lin, E David Crawford, Thomas Keane, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated RadiationJonathan Tward, Lauren Lenz, Darl D Flake, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 16, 2023
Automating Ground Truth Annotations for Gland Segmentation Through ImmunohistochemistryTushar Kataria, Saradha Rajamani, Abdul Bari Ayubi, et al.
Future Science OA|September 9, 2017
Analytical validation of a 12-gene molecular test for the prediction of distant recurrence in breast cancerM Bryan Warf, Saradha Rajamani, Kristin Krappmann, et al.
Cancer Reports (Hoboken, N.J.)|August 23, 2021
Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsyJack M Cuzick, Steven Stone, Lauren Lenz, et al.
Cancer Biomarkers : Section a of Disease Markers|September 26, 2015
Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resectionEric J Askeland, Vincent A Chehval, Ryan W Askeland, et al.
European Urology|November 5, 2018
Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate CancerDaniel J Canter, Julia Reid, Maria Latsis, et al.
Prostate Cancer and Prostatic Diseases|June 28, 2019
Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapyDaniel J Canter, Stephen Freedland, Saradha Rajamani, et al.
Urologic Oncology|April 16, 2018
Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillanceDaniel W Lin, E David Crawford, Thomas Keane, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated RadiationJonathan Tward, Lauren Lenz, Darl D Flake, et al.
Pageof 1